While Cementing Partnership With U.S. Biotech Firm, Cash-rich Simcere Launches Twin Acquisitions Targeting Biosimilar, Vaccine Outfits In China

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.